Robert Daniel Martin serves as Executive at HedgePath Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert Daniel Martin has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 20, 2018 involved receiving (via award) 60,000 shares valued at $4.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 20, 2018 | HPPI | $4.8K | Award | 60,000 | $0.08 | Discretionary |
Robert Daniel Martin currently holds 116,000 shares of HedgePath Pharmaceuticals, Inc. (HPPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Daniel Martin has been a net neutral trader of HPPI stock. They have purchased $0 and sold $0 worth of shares.
Robert Daniel Martin's most recent insider trade was on Dec 20, 2018, when they sold 60,000 shares at $0.08 per share.
Get notified when new Form 4 filings are submitted